Summary
This 8-K filing from Anthem, Inc. (now Elevance Health, Inc.) on February 23, 2016, primarily announces a significant change in its corporate governance. Effective February 18, 2016, the company amended its By-Laws to implement proxy access, a policy that allows eligible shareholders to nominate directors directly on the company's proxy card. This move is investor-focused as it provides shareholders with greater influence over board composition. The new by-laws permit a shareholder, or a group of up to 20 shareholders, collectively holding at least 3% of the company's stock for a minimum of three years, to nominate director candidates. These nominees can represent up to 20% of the board or two individuals, whichever is greater, subject to meeting specific requirements outlined in the By-Laws. This policy change is intended to align the company's governance practices with evolving shareholder expectations and enhance board accountability.
Key Highlights
- 1Anthem, Inc. (now Elevance Health) amended its By-Laws to implement proxy access.
- 2Proxy access allows eligible shareholders to nominate director candidates for inclusion on the company's proxy card.
- 3To be eligible, shareholders must own at least 3% of outstanding common stock continuously for at least 3 years.
- 4A group of up to 20 shareholders can aggregate their holdings to meet the 3% ownership threshold.
- 5Eligible shareholders can nominate director candidates constituting up to the greater of 20% of the Board or 2 individuals.
- 6The new by-laws also updated Advance Notice provisions to accommodate proxy access nominations.
- 7This change aims to enhance shareholder engagement and influence over board composition.